Connor, Clark & Lunn Investment Management (CC&L)
CARM

Connor, Clark & Lunn Investment Management (CC&L)’s Carisma Therapeutics CARM Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
2024
Q1 		$29.6K Buy
2023
Q3 		– Sell
2023
Q2 		$130K Hold
2023
Q1 		$45.9K Buy
2022
Q4 		$96K Buy
2022
Q3 		$61K Buy
2016
Q1 		– Sell
2015
Q4 		$77K Hold
2015
Q3 		$61K Buy
2015
Q2 		$65K Buy